7 News & Press Releases found
Neuros Medical, Inc. News
-
Neuros Medical Announces Completion of QUEST Pivotal Trial 90-day Primary Endpoints
Neuros Medical, Inc., a medical device company developing an innovative, on-demand bioelectric nerve block therapy for patients with intractable post-amputation pain, announced today the completion of its QUEST Pivotal Trial 90-day primary ...
-
Neuros Medical Announces Completion of Enrollment in the QUEST Pivotal Clinical Study for Chronic Post-Amputation Pain
Neuros Medical, Inc., a medical device company developing innovative high-frequency nerve block technology for patients with intractable post-amputation pain, announced today the completion of enrollment in its pivotal QUEST (High-FreQUEncy Nerve ...
-
Neuros Medical Receives FDA Breakthrough Device Designation for its Novel Altius High Frequency Nerve Block System
Neuros Medical, Inc., announced today that it has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for the use of its novel High-Frequency Nerve Block system as an aid in the management of chronic intractable ...
-
Neuros Medical Raises $38.5M in Series BB Funding for Completion of Pivotal Clinical Study for Chronic Post-Amputation Pain
Neuros Medical, Inc., a medical device company developing innovative high-frequency nerve block technology for patients with intractable post-amputation pain, announced today the close of a Series BB financing totaling $38.5 million. The financing ...
-
Neuros Medical Announces Key Milestones in the QUEST Pivotal Clinical Study for Chronic Post-Amputation Pain
Neuros Medical, Inc., a medical device company developing innovative high-frequency nerve block technology for patients with intractable post-amputation pain, announced today the achievement of two milestones in its pivotal QUEST ...
-
Neuros Medical Appoints Tom Wilder as President and CEO
Neuros Medical, Inc., a neuromodulation company, announced today the appointment of Tom Wilder as President and CEO. Mr. Wilder has over 30 years of experience, having most recently led Sequent Medical, Inc., a neurovascular company that developed ...
-
Neuros Medical Announces Closing of $20 Million Venture Financing
Neuros Medical, Inc., a neuromodulation company, announced today that it has closed a $20 million Series AA venture capital financing. U.S. Venture Partners led the financing, and was joined by Boston Scientific, Aperture Venture Partners, Osage ...